Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dextroamphetamine for Comorbid Cocaine Dependence and ADHD
NCT00514202Phase 2Terminated
- Sponsor
- UTHealth Houston
- Start
- Aug 2007
- Primary completion
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dextroamphetamine in cocaine dependence, attention deficit hyperactivity disorder (ADHD), sponsored by UTHealth Houston. Started Aug 2007; status: terminated.
02
Drugs
dextroamphetamine
03
Conditions
cocaine dependenceattention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT00514202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00514202.